The neurological response to coronavirus disease 2019 (COVID-19) may be due to brain-brain barrier (BBB) disruption.
Cipla to bolster OTC portfolio with acquisition of Actor Pharma
Actor Pharma is the fifth-largest over-the-counter player in the private market in South Africa. Credit: one photo/Shutterstock.com. Indian pharmaceutical company Cipla’s wholly owned subsidiary, Cipla